109 related articles for article (PubMed ID: 16421932)
1. Runx2 phosphorylation induced by fibroblast growth factor-2/protein kinase C pathways.
Kim BG; Kim HJ; Park HJ; Kim YJ; Yoon WJ; Lee SJ; Ryoo HM; Cho JY
Proteomics; 2006 Feb; 6(4):1166-74. PubMed ID: 16421932
[TBL] [Abstract][Full Text] [Related]
2. Effect of fibroblast growth factor 9 on Runx2 gene promoter activity in MC3T3-E1 and C2C12 cells.
Yu LY; Pei Y; Xia WB; Xing XP; Meng XW; Zhou XY
Chin Med J (Engl); 2007 Mar; 120(6):491-5. PubMed ID: 17439743
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the osteoblast-specific transcription factor, Runx2: responsiveness to multiple signal transduction pathways.
Franceschi RT; Xiao G
J Cell Biochem; 2003 Feb; 88(3):446-54. PubMed ID: 12532321
[TBL] [Abstract][Full Text] [Related]
4. Runx2 regulates FGF2-induced Bmp2 expression during cranial bone development.
Choi KY; Kim HJ; Lee MH; Kwon TG; Nah HD; Furuichi T; Komori T; Nam SH; Kim YJ; Kim HJ; Ryoo HM
Dev Dyn; 2005 May; 233(1):115-21. PubMed ID: 15765505
[TBL] [Abstract][Full Text] [Related]
5. Mechanical stress-mediated Runx2 activation is dependent on Ras/ERK1/2 MAPK signaling in osteoblasts.
Kanno T; Takahashi T; Tsujisawa T; Ariyoshi W; Nishihara T
J Cell Biochem; 2007 Aug; 101(5):1266-77. PubMed ID: 17265428
[TBL] [Abstract][Full Text] [Related]
6. The protein kinase C pathway plays a central role in the fibroblast growth factor-stimulated expression and transactivation activity of Runx2.
Kim HJ; Kim JH; Bae SC; Choi JY; Kim HJ; Ryoo HM
J Biol Chem; 2003 Jan; 278(1):319-26. PubMed ID: 12403780
[TBL] [Abstract][Full Text] [Related]
7. CCAAT/enhancer-binding protein delta activates the Runx2-mediated transcription of mouse osteocalcin II promoter.
Shin CS; Jeon MJ; Yang JY; Her SJ; Kim D; Kim SW; Kim SY
J Mol Endocrinol; 2006 Jun; 36(3):531-46. PubMed ID: 16720721
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor 2 induction of the osteocalcin gene requires MAPK activity and phosphorylation of the osteoblast transcription factor, Cbfa1/Runx2.
Xiao G; Jiang D; Gopalakrishnan R; Franceschi RT
J Biol Chem; 2002 Sep; 277(39):36181-7. PubMed ID: 12110689
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the Runx2 promoter in osseous and non-osseous cells and identification of HIF2A as a potent transcription activator.
Tamiya H; Ikeda T; Jeong JH; Saito T; Yano F; Jung YK; Ohba S; Kawaguchi H; Chung UI; Choi JY
Gene; 2008 Jun; 416(1-2):53-60. PubMed ID: 18442887
[TBL] [Abstract][Full Text] [Related]
10. The suppressive effect of myeloid Elf-1-like factor (MEF) in osteogenic differentiation.
Kim YJ; Kim BG; Lee SJ; Lee HK; Lee SH; Ryoo HM; Cho JY
J Cell Physiol; 2007 Apr; 211(1):253-60. PubMed ID: 17167770
[TBL] [Abstract][Full Text] [Related]
11. Bone morphogenic protein 2 induces Runx2 and osteopontin expression in human aortic valve interstitial cells: role of Smad1 and extracellular signal-regulated kinase 1/2.
Yang X; Meng X; Su X; Mauchley DC; Ao L; Cleveland JC; Fullerton DA
J Thorac Cardiovasc Surg; 2009 Oct; 138(4):1008-15. PubMed ID: 19664780
[TBL] [Abstract][Full Text] [Related]
12. Mitogen activated protein kinase-dependent inhibition of osteocalcin gene expression by transforming growth factor-beta1.
Kwok S; Partridge NC; Srinivasan N; Nair SV; Selvamurugan N
J Cell Biochem; 2009 Jan; 106(1):161-9. PubMed ID: 19051235
[TBL] [Abstract][Full Text] [Related]
13. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
[TBL] [Abstract][Full Text] [Related]
14. Expression of the SNT-1/FRS2 phosphotyrosine binding domain inhibits activation of MAP kinase and PI3-kinase pathways and antiestrogen resistant growth induced by FGF-1 in human breast carcinoma cells.
Manuvakhova M; Thottassery JV; Hays S; Qu Z; Rentz SS; Westbrook L; Kern FG
Oncogene; 2006 Sep; 25(44):6003-14. PubMed ID: 16682955
[TBL] [Abstract][Full Text] [Related]
15. Wnt induction of chondrocyte hypertrophy through the Runx2 transcription factor.
Dong YF; Soung do Y; Schwarz EM; O'Keefe RJ; Drissi H
J Cell Physiol; 2006 Jul; 208(1):77-86. PubMed ID: 16575901
[TBL] [Abstract][Full Text] [Related]
16. Modulation of human estrogen receptor alpha F promoter by a protein kinase C/c-Src-dependent mechanism in osteoblast-like cells.
Longo M; Peruzzi B; Fortunati D; De Luca V; Denger S; Caselli G; Migliaccio S; Teti A
J Mol Endocrinol; 2006 Dec; 37(3):489-502. PubMed ID: 17170089
[TBL] [Abstract][Full Text] [Related]
17. [Mechanism of transcriptional regulation by Runx2 in osteoblasts].
Komori T
Clin Calcium; 2006 May; 16(5):801-7. PubMed ID: 16679622
[TBL] [Abstract][Full Text] [Related]
18. O-GlcNAc modification modulates the expression of osteocalcin via OSE2 and Runx2.
Kim SH; Kim YH; Song M; An SH; Byun HY; Heo K; Lim S; Oh YS; Ryu SH; Suh PG
Biochem Biophys Res Commun; 2007 Oct; 362(2):325-9. PubMed ID: 17707335
[TBL] [Abstract][Full Text] [Related]
19. In vivo and in vitro comparison of the effects of FGF-2 null and haplo-insufficiency on bone formation in mice.
Naganawa T; Xiao L; Abogunde E; Sobue T; Kalajzic I; Sabbieti M; Agas D; Hurley MM
Biochem Biophys Res Commun; 2006 Jan; 339(2):490-8. PubMed ID: 16298332
[TBL] [Abstract][Full Text] [Related]
20. Runx2: of bone and stretch.
Ziros PG; Basdra EK; Papavassiliou AG
Int J Biochem Cell Biol; 2008; 40(9):1659-63. PubMed ID: 17656144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
